| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.78.4.1751-1762.2004 |
| P8608 | Fatcat ID | release_kyiwxmll7jgbpdd7biayewltrm |
| P932 | PMC publication ID | 369430 |
| P698 | PubMed publication ID | 14747540 |
| P50 | author | Todd D. Schell | Q47136559 |
| P2093 | author name string | Todd D Schell | |
| P2860 | cites work | Human tumor antigens recognized by T lymphocytes | Q24678508 |
| T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
| Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy | Q30305530 | ||
| Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. | Q30452613 | ||
| Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen | Q30452642 | ||
| Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules | Q32063827 | ||
| Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses | Q33652450 | ||
| Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. | Q33785966 | ||
| Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. | Q33815865 | ||
| An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope | Q34069951 | ||
| Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. | Q34155839 | ||
| Prostate cancer in a transgenic mouse | Q34444393 | ||
| Mechanisms of MHC class I--restricted antigen processing | Q34468834 | ||
| Peripheral selection of the T cell repertoire | Q34880495 | ||
| Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes | Q35093159 | ||
| Inducing autoimmune disease to treat cancer | Q35976297 | ||
| Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes | Q36231676 | ||
| Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism | Q36351357 | ||
| Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules | Q36356209 | ||
| Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions | Q36366583 | ||
| T cell affinity maturation by selective expansion during infection | Q36367796 | ||
| Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers | Q36375751 | ||
| T cells compete for access to antigen-bearing antigen-presenting cells | Q36376071 | ||
| Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. | Q36376876 | ||
| Endogenous Myelin Basic Protein Inactivates the High Avidity T Cell Repertoire | Q36401074 | ||
| Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. | Q36641930 | ||
| Comparative analysis of core amino acid residues of H-2D(b)-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen | Q36656271 | ||
| Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes | Q38310540 | ||
| Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice | Q40132698 | ||
| Biology of simian virus 40 (SV40) transplantation antigen (TrAg). V In vitro demonstration of SV40 TrAg in SV40 infected nonpermissive mouse cells by the lymphocyte mediated cytotoxicity assay | Q40248778 | ||
| Dominance and crypticity of T cell antigenic determinants | Q40486347 | ||
| Tumor antigens recognized by T lymphocytes | Q40661131 | ||
| Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumo | Q40695606 | ||
| HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy | Q40730426 | ||
| Control of Advanced Choroid Plexus Tumors in SV40 T Antigen Transgenic Mice Following Priming of Donor CD8+ T Lymphocytes by the Endogenous Tumor Antigen | Q40764447 | ||
| Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas | Q40874720 | ||
| Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. | Q40974006 | ||
| High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. | Q40978441 | ||
| T-cell-receptor affinity and thymocyte positive selection | Q41192128 | ||
| Harnessing self-reactivity in cancer immunotherapy | Q41258118 | ||
| Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen | Q41351864 | ||
| Epitope Specificity of H-2Kb-Restricted, HSV-1-, and HSV-2-Cross-Reactive Cytotoxic T Lymphocyte Clones | Q41546482 | ||
| Low avidity recognition of self-antigen by T cells permits escape from central tolerance. | Q41671634 | ||
| Loss of Immunorecessive Cytotoxic T Lymphocyte Determinant V on SV40 T Antigen following Cocultivation with Site-Specific Cytotoxic T Lymphocyte Clone Y-5 | Q41757179 | ||
| A comparison of several lines of transgenic mice containing the SV40 early genes | Q43901309 | ||
| The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules | Q44625079 | ||
| Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes | Q44851100 | ||
| Evidence for a differential avidity model of T cell selection in the thymus | Q45155438 | ||
| How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model | Q45783598 | ||
| Frequency analysis of simian virus 40-specific cytotoxic T lymphocyte precursors in the high responder C57BL/6 mouse strain | Q45847527 | ||
| Preferential escape of subdominant CD8+ T cells during negative selection results in an altered antiviral T cell hierarchy | Q45857950 | ||
| Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes | Q47877315 | ||
| Differential Tolerance Is Induced in T Cells Recognizing Distinct Epitopes of Myelin Basic Protein | Q47992214 | ||
| SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice | Q48467800 | ||
| Tracing and characterization of the low-avidity self-specific T cell repertoire | Q52026927 | ||
| T cell tolerance by clonal elimination in the thymus | Q56922465 | ||
| T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity | Q56929107 | ||
| Influence of antigen density on degree of clonal deletion in T cell receptor transgenic mice | Q57275615 | ||
| Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. | Q57275625 | ||
| Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity | Q61140536 | ||
| Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas | Q63533103 | ||
| Comparison of the T cell receptors on insulin-specific hybridomas from insulin transgenic and nontransgenic mice. Loss of a subpopulation of self-reactive clones | Q67897410 | ||
| Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen | Q69017585 | ||
| Localization of an immunorecessive epitope on SV40 T antigen by H-2Db-restricted cytotoxic T-lymphocyte clones and a synthetic peptide | Q69081495 | ||
| Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen | Q71420846 | ||
| Dose-dependent T cell tolerance to an immunodominant self peptide | Q72119394 | ||
| Positive and negative thymocyte selection induced by different concentrations of a single peptide | Q72293139 | ||
| Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels | Q72710850 | ||
| Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance | Q72932981 | ||
| Quantitative analysis of the T cell repertoire that escapes negative selection | Q73152040 | ||
| Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion | Q73406538 | ||
| Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or | Q73976494 | ||
| Avoiding tolerance against prostatic antigens with subdominant peptide epitopes | Q73979260 | ||
| Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR | Q74286685 | ||
| Adoptive immunotherapy prevents prostate cancer in a transgenic animal model | Q77402462 | ||
| Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR | Q77522368 | ||
| Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma | Q77841504 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | SV40 | Q734305 |
| P304 | page(s) | 1751-1762 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice | |
| P478 | volume | 78 |
| Q37098207 | CD8+ T-cell cross-competition is governed by peptide-MHC class I stability |
| Q34071227 | Combined anti-CD40 conditioning and well-timed immunization prolongs CD8+ T cell accumulation and control of established brain tumors |
| Q37400231 | Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones |
| Q37754754 | Factors influencing immunodominance hierarchies in TCD8+ -mediated antiviral responses |
| Q36505831 | Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells |
| Q41931832 | PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination. |
| Q34216825 | Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors |
| Q39242362 | Short-term corticosterone treatment decreases the early CD8+ T cell response to simian virus 40 tumor antigen but has no impact on the late CD8+ T cell response |
Search more.